randomisation sequence Search Results


dental caries single-cell rna sequencing mendelian randomisation genetic susceptibility oral health sequencing  (Taihe Biotechnology Co Ltd)
90
Taihe Biotechnology Co Ltd dental caries single-cell rna sequencing mendelian randomisation genetic susceptibility oral health sequencing
Dental Caries Single Cell Rna Sequencing Mendelian Randomisation Genetic Susceptibility Oral Health Sequencing, supplied by Taihe Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dental caries single-cell rna sequencing mendelian randomisation genetic susceptibility oral health sequencing/product/Taihe Biotechnology Co Ltd
Average 90 stars, based on 1 article reviews
dental caries single-cell rna sequencing mendelian randomisation genetic susceptibility oral health sequencing - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (GANZONI GmbH)
90
GANZONI GmbH randomisation sequence
Randomisation Sequence, supplied by GANZONI GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/GANZONI GmbH
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (Biostatistical Consulting)
90
Biostatistical Consulting randomisation sequence
Randomisation Sequence, supplied by Biostatistical Consulting, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/Biostatistical Consulting
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
random sequence generation  (Janssen)
90
Janssen random sequence generation
Random Sequence Generation, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/random sequence generation/product/Janssen
Average 90 stars, based on 1 article reviews
random sequence generation - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
computer-generated randomisation sequence  (Questback GmbH)
90
Questback GmbH computer-generated randomisation sequence
Study assessment
Computer Generated Randomisation Sequence, supplied by Questback GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer-generated randomisation sequence/product/Questback GmbH
Average 90 stars, based on 1 article reviews
computer-generated randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (Nycomed)
90
Nycomed randomisation sequence
Study assessment
Randomisation Sequence, supplied by Nycomed, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/Nycomed
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (AstraZeneca ltd)
90
AstraZeneca ltd randomisation sequence
Study assessment
Randomisation Sequence, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/AstraZeneca ltd
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
stratified randomisation sequence  (SAS institute)
90
SAS institute stratified randomisation sequence
Study assessment
Stratified Randomisation Sequence, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/stratified randomisation sequence/product/SAS institute
Average 90 stars, based on 1 article reviews
stratified randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (EPS Corporation)
90
EPS Corporation randomisation sequence
Ajani 2010
Randomisation Sequence, supplied by EPS Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/EPS Corporation
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
computer-generated randomisation sequence  (ICON Clinical Research)
90
ICON Clinical Research computer-generated randomisation sequence
Ajani 2010
Computer Generated Randomisation Sequence, supplied by ICON Clinical Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/computer-generated randomisation sequence/product/ICON Clinical Research
Average 90 stars, based on 1 article reviews
computer-generated randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (EMMES Corporation)
90
EMMES Corporation randomisation sequence
Trial profile <t>Randomisation</t> into inpatient (LAIV8-IIV5/AS03, LAIV8-IIV5, and sterile saline placebo control) and outpatient (IIV8/AS03-IIV5/AS03 and phosphate buffered saline placebo control) groups is shown. * 66 randomly assigned, with one ineligible participant included in error and excluded after randomisation.
Randomisation Sequence, supplied by EMMES Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/EMMES Corporation
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
randomisation sequence  (Novartis)
90
Novartis randomisation sequence
Trial profile <t>Randomisation</t> into inpatient (LAIV8-IIV5/AS03, LAIV8-IIV5, and sterile saline placebo control) and outpatient (IIV8/AS03-IIV5/AS03 and phosphate buffered saline placebo control) groups is shown. * 66 randomly assigned, with one ineligible participant included in error and excluded after randomisation.
Randomisation Sequence, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/randomisation sequence/product/Novartis
Average 90 stars, based on 1 article reviews
randomisation sequence - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Study assessment

Journal: Pilot and Feasibility Studies

Article Title: Impact of a multimedia website with patient experiences of multiple sclerosis (PExMS) on immunotherapy decision-making: study protocol for a pilot randomised controlled trial in a mixed-methods design

doi: 10.1186/s40814-020-00749-0

Figure Lengend Snippet: Study assessment

Article Snippet: The concealed allocation sequence will be computer-generated by the randomisation sequence of QuestBack Unipark.

Techniques:

Ajani 2010

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Ajani 2010

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Sequencing, Selection

Al‐Batran 2013

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Al‐Batran 2013

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Biomarker Discovery, Sequencing, Selection

Barone 1998

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Barone 1998

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Control, Sequencing, Selection

Bouche 2004

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Bouche 2004

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Adjuvant, Sequencing, Selection

Dank 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Dank 2008

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Adjuvant, Sequencing, Selection

Hironaka 2016

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Hironaka 2016

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Control, Sequencing, Selection, Generated

Huang 2013

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Huang 2013

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Sequencing, Selection

Lutz 2007

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Lutz 2007

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Sequencing, Selection, Computed Tomography

Nishikawa 2012

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Nishikawa 2012

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Sequencing, Selection

Ocvirk 2012

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Ocvirk 2012

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Biomarker Discovery, Sequencing, Selection

Roth 2007

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Roth 2007

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Biomarker Discovery, Sequencing, Selection

Yamada 2015

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: Yamada 2015

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Sequencing, Selection, Generated, Expressing

NCT02076594

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: NCT02076594

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques: Biomarker Discovery, Control

NCT03006432

Journal: The Cochrane Database of Systematic Reviews

Article Title: Chemotherapy for advanced gastric cancer

doi: 10.1002/14651858.CD004064.pub4

Figure Lengend Snippet: NCT03006432

Article Snippet: Allocation concealment (selection bias) , Low risk , Randomisation sequence was generated by EPS Corporation (Tokyo, Japan) independently from the study sponsor.

Techniques:

Trial profile Randomisation into inpatient (LAIV8-IIV5/AS03, LAIV8-IIV5, and sterile saline placebo control) and outpatient (IIV8/AS03-IIV5/AS03 and phosphate buffered saline placebo control) groups is shown. * 66 randomly assigned, with one ineligible participant included in error and excluded after randomisation.

Journal: The Lancet. Infectious Diseases

Article Title: Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

doi: 10.1016/S1473-3099(19)30393-7

Figure Lengend Snippet: Trial profile Randomisation into inpatient (LAIV8-IIV5/AS03, LAIV8-IIV5, and sterile saline placebo control) and outpatient (IIV8/AS03-IIV5/AS03 and phosphate buffered saline placebo control) groups is shown. * 66 randomly assigned, with one ineligible participant included in error and excluded after randomisation.

Article Snippet: The randomisation sequence was generated independently by a contract research organisation, Emmes Corporation.

Techniques: Sterility, Saline, Control